XJPX
653A
, Last price
JPY
Name
MabGenesis Inc.
Chart & performance
P/E
—
P/S
—
EPS
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
Net income
CFO
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MabGenesis Inc., a biopharmaceutical company, engages in the research, discovery, development, and commercialization of therapeutic monoclonal antibody drugs for human and animal healthcare applications in Japan. The company offers proprietary antibody discovery platforms, including MOURA Libraries and IMPACT antibody isolation technology, to develop antibody therapeutics. The company was incorporated in 2019 and is based in Yokohama, Japan.
Key people
Jin Kurosawa
CTO
Ryu Maeda
Executive Officer
Yuichiro Shibasaki
Executive Officer
Katsuhiro Shinjo
Representative Director
Mayu Morishima
Independent Director
Valuation
No data to show